Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Venlafaxine versus bupropion in adults with type 2 diabetes mellitus and depression
IRCT20150630022991N12Phase 2Completed
- Sponsor
- Babol University of Medical Sciences
- Start
- Aug 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial in major depressive disorder (MDD) comparing Venlafaxine arm with Bupropion arm (2 arms). Primary endpoints: Depressive symptoms and Blood glucose. Started Aug 2018; status: completed.
02
Drugs
venlafaxinebupropion
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on IRCT20150630022991N12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20150630022991N12.